title: Differential regulation of resveratrol on lipopolysacchride-stimulated human macrophages with or without IFN-gamma pre-priming.
abstract: Resveratrol, a polyphenol compound found in grapes and red wines, is a prominent anti-cancer agent. In this study, we demonstrate that resveratrol enhanced TNF-alpha, IL-12 and IL-1beta production from LPS activated phorbol myristate acetate (PMA) differentiated THP-1 human macrophages. Expression of CD86 on macrophages was enhanced by resveratrol alone and with LPS. When macrophages were primed with IFN-gamma, resveratrol suppressed the expression of HLA-ABC, HLA-DR, CD80, CD86 and inhibited production of TNF-alpha, IL-12, IL-6 and IL-1beta induced by LPS. The differential impact of resveratrol on expression of CD14 might be correlated with differential response of macrophages to LPS with or without IFN-gamma priming.
authors.affiliation: State Key Lab of Drug Research, Shanghai Institutes of Biological Sciences, Chinese Academy of Sciences. Shanghai 201203, PR China.
authors.forename: Yong-Hong
authors.initials: YH
authors.lastname: Feng
authors.forename: Yi-Na
authors.initials: YN
authors.lastname: Zhu
authors.forename: Jin
authors.initials: J
authors.lastname: Liu
authors.forename: Yong-Xing
authors.initials: YX
authors.lastname: Ren
authors.forename: Jian-Yi
authors.initials: JY
authors.lastname: Xu
authors.forename: Yi-Fu
authors.initials: YF
authors.lastname: Yang
authors.forename: Xiao-Yu
authors.initials: XY
authors.lastname: Li
authors.forename: Jian-Ping
authors.initials: JP
authors.lastname: Zou
mesh_terms: D000938:Antigen-Presenting Cells / Q000187:drug effects; D015703:Antigens, CD / Q000096:biosynthesis; D051940:B7-2 Antigen; D016923:Cell Death / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D016207:Cytokines / Q000096:biosynthesis; D004797:Enzyme-Linked Immunosorbent Assay; D005434:Flow Cytometry; D006801:Humans; D066298:In Vitro Techniques; D007371:Interferon-gamma / Q000494:pharmacology*; D007375:Interleukin-1 / Q000096:biosynthesis; D018664:Interleukin-12 / Q000096:biosynthesis; D018950:Lipopolysaccharide Receptors / Q000096:biosynthesis; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008264:Macrophages / Q000187:drug effects*; D008562:Membrane Glycoproteins / Q000096:biosynthesis; D010641:Phenotype; D011994:Recombinant Proteins; D000077185:Resveratrol; D013267:Stilbenes / Q000494:pharmacology*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D013778:Tetrazolium Salts; D013844:Thiazoles; D013936:Thymidine / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
chemical_list: D015703:Antigens, CD; D051940:B7-2 Antigen; C497964:CD86 protein, human; D016207:Cytokines; D007375:Interleukin-1; D018950:Lipopolysaccharide Receptors; D008070:Lipopolysaccharides; D008562:Membrane Glycoproteins; D011994:Recombinant Proteins; D013267:Stilbenes; D013778:Tetrazolium Salts; D013844:Thiazoles; D014409:Tumor Necrosis Factor-alpha; D018664:Interleukin-12; D007371:Interferon-gamma; C022616:thiazolyl blue; D013755:Tetradecanoylphorbol Acetate; D000077185:Resveratrol; D013936:Thymidine